Evidence map›Paper›PMID 31023658›Full record

ArticleAJNR. American journal of neuroradiology2019

Susceptibility-Weighted Angiography for the Follow-Up of Brain Arteriovenous Malformations Treated with Stereotactic Radiosurgery.

S Finitsis, R Anxionnat, B Gory, S Planel, L Liao, S Bracard

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S FinitsisAHEPA Hospital (S.F.), Aristotle University of Thessaloniki, Thessaloniki, Greece. stefanosfin@yahoo.com.ORCID 0000-0003-2140-7881
R AnxionnatFrom the Department of Neuroradiology (R.A., B.G., S.P., L.L., S.B.), Centre Hospitalier Universitaire de Nancy, Nancy, France.ORCID 0000-0001-6112-0661
B GoryFrom the Department of Neuroradiology (R.A., B.G., S.P., L.L., S.B.), Centre Hospitalier Universitaire de Nancy, Nancy, France.ORCID 0000-0001-8424-4464
S PlanelFrom the Department of Neuroradiology (R.A., B.G., S.P., L.L., S.B.), Centre Hospitalier Universitaire de Nancy, Nancy, France.ORCID 0000-0001-5913-2268
L LiaoFrom the Department of Neuroradiology (R.A., B.G., S.P., L.L., S.B.), Centre Hospitalier Universitaire de Nancy, Nancy, France.ORCID 0000-0003-3745-3372
S BracardFrom the Department of Neuroradiology (R.A., B.G., S.P., L.L., S.B.), Centre Hospitalier Universitaire de Nancy, Nancy, France.ORCID 0000-0001-9423-6660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The criterion standard for assessing brain AVM obliteration postradiosurgery is DSA. To explore the value of susceptibility-weighted angiography, we followed 26 patients with brain AVMs treated by radiosurgery using susceptibility-weighted angiography and DSA. Studies were evaluated by 2 independent readers for residual nidi. Susceptibility-weighted angiography demonstrated good intermodality (κ = 0.71) and interobserver (κ = 0.64) agreement, and good sensitivity (85.7%) and specificity (85.7%). Susceptibility-weighted angiography is a useful radiation- and contrast material-free technique to follow-up brain AVM obliteration postradiosurgery.

Indexed as

AdultArteriovenous FistulaFemaleFollow-Up StudiesHumansIntracranial Arteriovenous MalformationsMagnetic Resonance AngiographyMaleMiddle AgedNeuroimagingRadiosurgeryRetrospective StudiesSensitivity and SpecificityTreatment Outcome

Identifiers

PMID31023658
PMCPMC7053887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.